---
id: kawasaki-disease-treatment_046
category: clinical_syndromes
tags: [kawasaki-disease, IVIG, aspirin, treatment, pediatrics]
deck: Infectious Diseases
created: 2025-11-10
modified: 2025-11-10
---

## Kawasaki Disease: Treatment

**Q:** What is the standard treatment for Kawasaki disease, including dosing and management of IVIG-resistant cases?

**A:**

**Standard Treatment:**

**1. IVIG (Intravenous Immunoglobulin):**
- **Dose:** **2 g/kg** as single infusion over 8-12 hours
- **Timing:** As soon as possible, **ideally within 10 days** of fever onset
- **Goal:** Reduce inflammation, prevent coronary artery aneurysms

**2. Aspirin:**

| **Phase** | **Dose** | **Duration** | **Purpose** |
|-----------|----------|--------------|-------------|
| **Acute (anti-inflammatory)** | **30-100 mg/kg/day** divided q6h | Until afebrile x 48-72 hours | Anti-inflammatory, antipyretic |
| **Convalescent (antiplatelet)** | **3-5 mg/kg once daily** | 6-8 weeks (or longer if aneurysms) | Antiplatelet |

**Note:** 2024 evidence suggests medium/high-dose aspirin in acute phase may NOT improve coronary outcomes (debate ongoing).

**Treatment Timeline:**

| **Day** | **Action** |
|---------|------------|
| **Day 0** (Diagnosis) | Start IVIG 2 g/kg + aspirin 30-100 mg/kg/day |
| **Day 1-2** | Expect defervescence within 24-48 hours |
| **Day 2-3** (if afebrile x 48h) | ↓ Aspirin to 3-5 mg/kg daily |
| **Week 6-8** | Echocardiogram → if normal, stop aspirin |

**IVIG-Resistant Kawasaki (Persistent/Recrudescent Fever ≥36h Post-IVIG):**

**Occurs in:** 10-20% of patients

**Treatment Options:**

| **Option** | **Dosing** | **Notes** |
|------------|------------|-----------|
| **Second IVIG dose** | 2 g/kg x1 | First-line for IVIG-resistant |
| **High-dose methylprednisolone** | 20-30 mg/kg IV daily x 3 days | Consider if 2nd IVIG fails |
| **Infliximab (anti-TNF)** | 5 mg/kg IV x1 | Increasingly used, effective |
| **Cyclosporine, cyclophosphamide** | Variable | Refractory cases only |

**Important Considerations:**

**1. Live Vaccine Deferral:**
- MMR, varicella vaccines **deferred 11 months** after IVIG (antibody interference)

**2. Aspirin + Viral Illness:**
- **Stop aspirin** if exposed to influenza or varicella (Reye syndrome risk)
- Substitute with clopidogrel or other antiplatelet during viral illness

**3. Coronary Monitoring:**
- Echo at diagnosis, 2 weeks, 6-8 weeks
- If aneurysms: Long-term aspirin + possibly anticoagulation

**Mnemonic: "KD treatment = 2-2-2"**
- **2** g/kg IVIG (single dose)
- **2** phases of aspirin (high-dose → low-dose)
- **2** weeks for first follow-up echo

**Clinical Pearl:**
- **Early IVIG (<10 days)** reduces coronary aneurysm risk from 25% → <5%
- Don't delay treatment waiting for all criteria (incomplete KD needs treatment)
- If fever persists ≥36 hours post-IVIG, consider IVIG-resistant (retreat or escalate)

**Media:** None

**Sources:** [AHA 2024 - Kawasaki update], [UC Davis 2024 clinical guideline], [AAFP 2006 - AHA summary], [PMC 2023 - Treatment update], [Circulation 2024 - Long-term management]
